Myocyte enhancer factor 2: Difference between revisions
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| Line 15: | Line 15: | ||
== Disease == | == Disease == | ||
High expression of MEF2C is observed in leukemia<ref>PMID:23435431</ref>. | High expression of MEF2C is observed in leukemia<ref>PMID:23435431</ref>. Mutations in MEF2A are associated with coronary artery disease and myocardial infraction<ref>PMID:20031581</ref>. Mutations in MEF2B are associated with non-hodgkin lymphoma<ref>PMID:26245647</ref>. | ||
==Additional Resources== | ==Additional Resources== | ||
For Additional information, See [[Transcription and RNA Processing]] | For Additional information, See [[Transcription and RNA Processing]] | ||
== 3D Structures of | == 3D Structures of myocyte enhancer factor 2 == | ||
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||